22 results
8-K
EX-10.2
RNXT
RenovoRx Inc
3 Apr 23
RenovoRx, Inc. Announces $5 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
4:45pm
to result in a Material Adverse Effect. None of the Company’s or its Subsidiaries’ employees is a member of a union that relates to such employee’s
10-K
1znaif su
30 Mar 22
Annual report
7:21am
10-Q
oc79ck u15yd4ru2z
15 Nov 21
Quarterly report
12:00am
424B4
ni5n199a
27 Aug 21
Prospectus supplement with pricing info
6:06am
S-1/A
5i0f23cyngeinusr
5 Aug 21
IPO registration (amended)
5:29pm
S-1/A
EX-1.1
ar7xjkg
5 Aug 21
IPO registration (amended)
5:29pm
S-1
jboepl7 izhsski322t
21 Jul 21
IPO registration
5:15pm
DRS/A
jsjz9zp1rldik
15 Jun 21
Draft registration statement (amended)
12:00am